69496-75-9 Usage
Uses
Used in Research Applications:
5-Methoxy-N,N-dipropyltryptamine is used as a research chemical for the study of its psychoactive properties and potential effects on the central nervous system. It aids in understanding the mechanisms of action of tryptamine-class psychedelic drugs and their interactions with neurotransmitter systems.
Used in Forensic Applications:
In the forensic field, 5-methoxy DPT is used as a reference compound to help identify and analyze samples related to controlled substances. Its regulation as a Schedule I compound in the United States makes it a valuable tool for forensic laboratories in their efforts to detect and differentiate between various psychoactive substances.
Used in Pharmaceutical Development:
Although the physiological and toxicological properties of 5-methoxy DPT are not well-known, its use as a monoamine re-uptake inhibitor suggests potential applications in the development of new pharmaceuticals targeting neurotransmitter systems. Further research may lead to the discovery of novel treatments for various neurological and psychiatric disorders.
Used in Neurochemical Studies:
5-Methoxy-N,N-dipropyltryptamine is used as a research tool in neurochemical studies to investigate the re-uptake inhibition of dopamine, serotonin, and norepinephrine. Understanding the effects of 5-Methoxy-N,N-dipropyltryptamine on these neurotransmitters can provide insights into the development of new therapeutic strategies for conditions related to neurotransmitter imbalances.
Check Digit Verification of cas no
The CAS Registry Mumber 69496-75-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,9,4,9 and 6 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 69496-75:
(7*6)+(6*9)+(5*4)+(4*9)+(3*6)+(2*7)+(1*5)=189
189 % 10 = 9
So 69496-75-9 is a valid CAS Registry Number.
69496-75-9Relevant academic research and scientific papers
METHOD OF INHIBITING GASTRIC ACID SECRETION WITH BENZODIOXANES
-
, (2008/06/13)
The present invention provides a method of inhibiting gastric acid secretion in mammals by administering a 5-HT1A agonist compound or a pharmaceutically acceptable salt thereof.
METHOD OF INHIBITING GASTRIC ACID SECRETION
-
, (2008/06/13)
The present invention provides a method of inhibiting gastric acid secretion in mammals by administering a 5-HT1A agonist compound or a pharmaceutically acceptable salt thereof.
